| Financial Year |
March 31 2023 |
| Monetary Funds |
149,795,863,282.67 |
| Held-for-trading Financial Assets |
27,315,439,466.73 |
| Notes Receivable |
3,383,343,439.06 |
| Accounts Receivable |
62,256,723,976.40 |
| Advances to Suppliers |
21,226,994,403.77 |
| Other Receivables |
13,709,662,086.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
784,507,289.41 |
| Dividend Receivable |
1,087,618,198.87 |
| Inventories |
92,853,313,431.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
60,576,063,876.97 |
| Other Current Assets |
106,854,391,790.10 |
| Total Current Assets |
558,462,429,287.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
10,693,965,657.28 |
| Long-term Equity Investment |
63,967,568,718.31 |
| Investment Properties |
2,115,214,852.08 |
| Fixed Assetes |
80,423,983,530.54 |
| Under-construction Projects |
15,202,728,283.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
19,020,680,735.52 |
| R&D expenses |
3,272,413,646.94 |
| Goodwill |
1,227,749,062.61 |
| Long-Term Deferred and Prepaid Expenses |
2,671,513,929.10 |
| Deferred Income Tax Assets |
27,369,447,704.66 |
| Other Non-Current Assets |
10,722,980,951.92 |
| Sub-Total of Non-Current Assets |
389,666,330,875.04 |
| Total Assets |
948,128,760,162.07 |
| Short-Term Loans |
40,499,803,873.44 |
| Trading Financial liabilities |
134,925,261.68 |
| Notes Payable |
80,527,355,839.04 |
| Accounts Payable |
151,929,030,809.88 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,060,858,731.00 |
| Taxes Payable |
5,593,649,284.74 |
| Interest Payable |
92,245,299.04 |
| Dividend Payable |
481,480,753.99 |
| Other payables |
57,324,824,127.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
38,410,429,351.92 |
| Other Current Liabilities |
2,050,571,415.68 |
| Sub-Total of Current Liabilities |
501,093,127,871.24 |
| Long-term Loans |
35,804,514,696.52 |
| Bonds Payable |
10,196,569,859.89 |
| Long-Term Accounts Payable |
818,901,485.81 |
| Special Payable |
-- |
| Estimatied Liabilities |
19,156,004,772.84 |
| Deferred Income Tax Liabilities |
3,595,145,823.67 |
| Other Non-Current Liabilities |
3,044,092,512.38 |
| Sub-Total of Non-Current Liabilities |
107,068,704,497.79 |
| Total Liabilities |
608,161,832,369.03 |
| Paid-In Capital(Or Share Stock) |
11,683,461,365.00 |
| Capital Surplus |
57,904,718,454.43 |
| Surplus Reserve |
40,843,171,648.51 |
| LESS:Treasury Stock |
3,747,774,556.69 |
| Undistributed Profits |
159,689,911,526.06 |
| Minority Stockholder's Interest |
58,578,224,416.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
281,388,703,376.34 |
| Owner's Equity（Stockholder's Equity） |
339,966,927,793.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
948,128,760,162.07 |
